GlassScriptPhysician profile
Janie C Daniel
NPI 1750320933
$2,410.36
in general payments reported to CMS, 2019-2025
21 companies · $104 in 2025
The $104 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $859 · 2022: $803 · 2023: $334 · 2024: $311 · 2025: $104.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $748.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $748.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $658.53 | 2021-2023 | Lifevest |
| Neurocrine Biosciences, INC. | $243.75 | 2023-2025 | Ingrezza |
| Novartis Pharmaceuticals Corporation | $195.37 | 2021-2023 | |
| Merck Sharp & Dohme LLC | $188.26 | 2021-2022 | |
| Alnylam Pharmaceuticals INC. | $137.80 | 2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $127.50 | 2024 | Caplyta |
| Janssen Pharmaceuticals, INC | $125.51 | 2021-2022 | |
| Uswm, LLC | $108.54 | 2023 | Lucemyra, Zimhi |
| Amgen INC. | $101.56 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $95.88 | 2024 | Abilify Maintena, Abilify Asimtufii |
| Astrazeneca Pharmaceuticals LP | $74.90 | 2021 | |
| Amarin Pharma, INC. | $67.68 | 2021 | |
| Novo Nordisk INC | $56.59 | 2023-2025 | |
| Abbvie INC. | $45.88 | 2023-2024 | |
| Sanofi-Aventis U.S. LLC | $41.03 | 2022-2023 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $29.50 | 2022 | |
| Astellas Pharma US INC | $26.68 | 2021 | |
| Boston Scientific Corporation | $26.10 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.43 | 2021 | |
| Abbott Laboratories | $19.76 | 2021 | |
| Cranial Technologies, INC | $17.11 | 2023 | Doc Band |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janie Daniel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.